ReviewCephalalgia : an international journal of headache2019

A new era for migraine: Pharmacokinetic and pharmacodynamic insights into monoclonal antibodies with a focus on galcanezumab, an anti-CGRP antibody.

William Kielbasa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.